Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Oral Semaglutide

OASIS 1

Novo Nordisk · Phase 3 · Completed · Enrollment 667

NCT05035095

EudraCT 2020-002953-11

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Oral semaglutide173 participants80 participants89 participantsn/r0
Oral semaglutide placebo51 participants12 participants56 participantsn/r0

A count stays a count. This page does not turn a count into a percent.